Decreased rates of transmission of drug-resistant HIV-1 strains containing the M184V mutation in reverse transcriptase

被引：0
|
作者：
Turner, D
Brenner, BG
Routy, JP
Moisi, D
Wainberg, MA
机构：
[1] McGill Univ, AIDS Ctr, Montreal, PQ, Canada
[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
129
引用
收藏
页码：U123 / U124
页数：2
相关论文
共 50 条
  • [21] Multiple effects of the M184V resistance mutation in the reverse transcriptase of human immunodeficiency virus type 1
    Turner, D
    Brenner, B
    Wainberg, MA
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (06) : 979 - 981
  • [22] Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance
    Buckton, A. J.
    Prabhu, D.
    Motamed, C.
    Harris, R. J.
    Hill, C.
    Murphy, G.
    Parry, J. V.
    Johnson, J. A.
    Lowndes, C. M.
    Gill, N.
    Pillay, D.
    Cane, P. A.
    HIV MEDICINE, 2011, 12 (04) : 250 - 254
  • [23] Interplay of drugs and drug-resistant reverse transcriptase on HIV-1 mutant frequencies
    Mansky, LM
    Gajary, LC
    ANTIVIRAL THERAPY, 2002, 7 : S44 - S44
  • [24] Rates of transmission of antiretroviral drug resistant strains of HIV-1
    Ammaranond, P
    Cunningham, P
    Oelrichs, R
    Suzuki, K
    Harris, C
    Leas, L
    Grulich, A
    Cooper, DA
    Kelleher, AD
    JOURNAL OF CLINICAL VIROLOGY, 2003, 26 (02) : 153 - 161
  • [25] Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations
    Deval, J
    White, KL
    Miller, MD
    Parkin, NT
    Courcambeck, J
    Halfon, P
    Selmi, B
    Boretto, J
    Canard, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) : 509 - 516
  • [26] HIV-1 reverse transcriptase M184V and R212 K combined mutations conconfer phenotypic resistance to stavudine
    Nicastri, E
    Sarmati, L
    Parisi, SG
    D'Ettorre, C
    Narciso, F
    Vullo, V
    Andreoni, M
    AIDS, 2000, 14 : S112 - S112
  • [27] Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir
    Byun, Hyeonah
    Papathanasopoulos, Maria Antonia
    Steegen, Kim
    Basson, Adriaan Erasmus
    VIRUSES-BASEL, 2024, 16 (12):
  • [28] Effectiveness of 3TC in HIV clinical trials may be due in part to the M184V substitution in 3TC-resistant HIV-1 reverse transcriptase
    Wainberg, MA
    Hsu, M
    Gu, ZX
    Borkow, G
    Parniak, MA
    AIDS, 1996, 10 : S3 - S10
  • [29] Molecular modeling of HIV-1 reverse transcriptase drug-resistant mutant strains: implications for the mechanism of polymerase action
    Protein Eng, 12 (1379):
  • [30] Molecular modeling of HIV-1 reverse transcriptase drug-resistant mutant strains: implications for the mechanism of polymerase action
    Smith, MBK
    Michejda, CJ
    Hughes, SH
    Boyer, PL
    Janssen, PAJ
    Andries, K
    Buckheit, RW
    Smith, RH
    PROTEIN ENGINEERING, 1997, 10 (12): : 1379 - 1383
12345